封面
市場調查報告書
商品編碼
1770839

無標記陣列系統市場-全球產業規模、佔有率、趨勢、競爭、機會和預測,按類型、應用、最終用戶、地區和競爭細分,2020-2030 年

Label-free Array Systems Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type, By Application, By End user, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球無標記陣列系統市場價值為 5.3026 億美元,預計到 2030 年將達到 8.1411 億美元,預測期內複合年成長率為 7.41%。無標記陣列系統是一種先進的分析工具,無需螢光或放射性標記即可識別和定量生物分子。這些系統主要基於表面等離子體共振 (SPR) 原理,透過反射光的變化即時監測生物分子相互作用。個人化醫療、快速藥物開發、生物標記發現和特定蛋白質識別的需求日益成長,推動了無標記技術在研究和藥物發現中的應用。它們能夠對複雜的生物樣本進行動態、準確的分析,使其成為現代生物醫學研究中不可或缺的工具。

市場概覽
預測期 2026-2030
2024年市場規模 5.3026億美元
2030年市場規模 8.1411億美元
2025-2030 年複合年成長率 7.41%
成長最快的領域 合約研究組織(CRO)
最大的市場 北美洲

關鍵市場促進因素

藥物研發中對即時、高通量分析的需求日益成長

主要市場挑戰

設備成本高且基礎設施需求高

主要市場趨勢

與人工智慧和機器學習整合以進行數據解釋

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:全球無標記陣列系統市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型(表面電漿共振、生物層干涉法、細胞介電光譜法等)
    • 按應用(藥物發現、蛋白質界面分析、抗體表徵等)
    • 按最終用戶(製藥和生物技術公司、學術和研究機構、合約研究組織等)
    • 按公司分類(2024)
    • 按地區
  • 市場地圖

第6章:亞太地區無標記陣列系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第7章:歐洲無標記陣列系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章:北美無標記陣列系統市場展望。

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章:南美洲無標記陣列系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東與非洲無標記陣列系統市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 併購
  • 產品開發

第 13 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 14 章:無標記陣列系統市場:SWOT 分析

第 15 章:競爭格局

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Sartorius AG

第 16 章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15121

The Global Label-free Array Systems Market was valued at USD 530.26 million in 2024 and is projected to reach USD 814.11 million by 2030, growing at a CAGR of 7.41% during the forecast period. Label-free array systems are advanced analytical tools used for identifying and quantifying biomolecules without the need for fluorescent or radioactive labels. These systems operate primarily on the principle of Surface Plasmon Resonance (SPR), enabling real-time monitoring of biomolecular interactions through changes in reflected light. Increasing demand for personalized medicine, rapid drug development, biomarker discovery, and specific protein identification is driving the adoption of label-free technologies in research and drug discovery. Their ability to deliver dynamic, accurate analysis in complex biological samples positions them as indispensable tools in modern biomedical research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 530.26 Million
Market Size 2030USD 814.11 Million
CAGR 2025-20307.41%
Fastest Growing SegmentContract Research Organizations (CROs)
Largest MarketNorth America

Key Market Drivers

Increasing Demand for Real-Time, High-Throughput Analysis in Drug Discovery

The rising need for real-time, high-throughput screening technologies in pharmaceutical and biotechnological research is a major driver of the label-free array systems market. Traditional labeled assays are time-intensive and susceptible to inaccuracies due to interference from the labels themselves. Label-free array systems overcome these limitations by allowing direct observation of biomolecular interactions without tagging, providing valuable kinetic data. This is especially critical in early drug discovery stages where understanding drug-target affinities and interaction profiles can guide lead compound selection and optimization, significantly accelerating the development pipeline.

Key Market Challenges

High Cost of Equipment and Infrastructure Requirements

Despite offering cutting-edge capabilities, label-free array systems come with high capital and operational costs. The instruments often require specialized detection components-optical, acoustic, or electrochemical-which demand substantial financial investment and maintenance. Moreover, these systems frequently need controlled lab environments such as clean rooms or vibration-free setups, further increasing infrastructure costs. These financial constraints can hinder adoption in small- to mid-sized research facilities and institutions, particularly in low- and middle-income regions. Even in developed countries, funding limitations pose challenges for academia and SMEs unless supported by grants or partnerships, which remain competitive and limited in availability.

Key Market Trends

Integration with Artificial Intelligence and Machine Learning for Data Interpretation

The incorporation of artificial intelligence (AI) and machine learning (ML) technologies into label-free array systems is transforming how large-scale biological data is analyzed. These systems produce vast and complex datasets, particularly in proteomics and biomarker discovery. AI-driven analytics streamline data processing by detecting subtle patterns, improving signal clarity, and reducing background noise. This trend enhances both the accuracy and speed of research outputs. Globally, regulatory and research bodies are promoting AI integration in healthcare. The FDA's Digital Health Center of Excellence and the European Commission's Digital Europe Programme-with a €7.5 billion allocation-are key initiatives advancing AI-based biomedical innovation, supporting broader adoption of intelligent data analytics in label-free platforms.

Key Market Players

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Sartorius AG

Report Scope:

In this report, the Global Label-free Array Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Label-free Array Systems Market, By Type:

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Cellular Dielectric Spectroscopy
  • Others

Label-free Array Systems Market, By Application:

  • Drug Discovery
  • Protein Interface Analysis
  • Antibody Characterization
  • Others

Label-free Array Systems Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute
  • Contract Research Organization
  • Others
  • Ambulatory Care Centers
  • Others

Label-free Array Systems Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Label-free Array Systems Market.

Available Customizations:

Global Label-free Array Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-free Array Systems Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others)
    • 5.2.2. By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others)
    • 5.2.3. By End user (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. Asia-Pacific Label-free Array Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Label-free Array Systems Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End user
    • 6.3.2. India Label-free Array Systems Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End user
    • 6.3.3. South Korea Label-free Array Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End user
    • 6.3.4. Japan Label-free Array Systems Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End user
    • 6.3.5. Australia Label-free Array Systems Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End user

7. Europe Label-free Array Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Label-free Array Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End user
    • 7.3.2. Germany Label-free Array Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Label-free Array Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Label-free Array Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Label-free Array Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End user

8. North America Label-free Array Systems Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Label-free Array Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End user
    • 8.3.2. Mexico Label-free Array Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End user
    • 8.3.3. Canada Label-free Array Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End user

9. South America Label-free Array Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Label-free Array Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End user
    • 9.3.2. Argentina Label-free Array Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End user
    • 9.3.3. Colombia Label-free Array Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End user

10. Middle East and Africa Label-free Array Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Label-free Array Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End user
    • 10.3.2. Saudi Arabia Label-free Array Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End user
    • 10.3.3. UAE Label-free Array Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Label-free Array Systems Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Illumina, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. PerkinElmer, Inc.
  • 15.5. Merck KGaA
  • 15.6. Danaher Corporation
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. F. Hoffmann-La Roche Ltd.
  • 15.9. Becton, Dickinson and Company
  • 15.10. Sartorius AG

16. Strategic Recommendations

17. About Us & Disclaimer